Showing results (31-40 of 42) with videos related to
Sort By:
Pageof 5
Blood Advances|November 3, 2021
Vesicular trafficking is a key determinant of the statin response in acute myeloid leukemiaJana Krosl, Marie-Eve Bordeleau, Céline Moison, et al.Bone Marrow Transplantation|August 14, 2024
Isocitrate dehydrogenase (IDH) 1 and 2 mutations predict better outcome in patients with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation: a study of the ALWP of the EBMTRazan Mohty, Abdul Hamid Bazarbachi, Myriam Labopin, et al.EMBO Molecular Medicine|March 7, 2022
CDK7/12/13 inhibition targets an oscillating leukemia stem cell network and synergizes with venetoclax in acute myeloid leukemiaLixiazi He, Christian Arnold, Judith Thoma, et al.Nature Medicine|December 13, 2016
Loss of the histone methyltransferase EZH2 induces resistance to multiple drugs in acute myeloid leukemiaStefanie Göllner, Thomas Oellerich, Shuchi Agrawal-Singh, et al.Nature Cancer|February 5, 2022
Hotspot DNMT3A mutations in clonal hematopoiesis and acute myeloid leukemia sensitize cells to azacytidine via viral mimicry responseMarina Scheller, Anne Kathrin Ludwig, Stefanie Göllner, et al.Nature Cell Biology|June 27, 2017
AML1-ETO requires enhanced C/D box snoRNA/RNP formation to induce self-renewal and leukaemiaFengbiao Zhou, Yi Liu, Christian Rohde, et al.Cell Stem Cell|April 25, 2023
Clonally resolved single-cell multi-omics identifies routes of cellular differentiation in acute myeloid leukemiaSergi Beneyto-Calabuig, Anne Kathrin Merbach, Jonas-Alexander Kniffka, et al.Blood|July 20, 2022
Venetoclax synergizes with gilteritinib in FLT3 wild-type high-risk acute myeloid leukemia by suppressing MCL-1Maike Janssen, Christina Schmidt, Peter-Martin Bruch, et al.Cancer Cell|April 30, 2015
Inherited and Somatic Defects in DDX41 in Myeloid NeoplasmsChantana Polprasert, Isabell Schulze, Mikkael A Sekeres, et al.Leukemia|June 12, 2019
The neuropeptide receptor calcitonin receptor-like (CALCRL) is a potential therapeutic target in acute myeloid leukemiaLinus Angenendt, Eike Bormann, Caroline Pabst, et al.Pageof 5